Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Acceleron Pharma (XLRN) News Today

Acceleron Pharma logo
Acceleron Banks on Muons for Colder Fusion
ORBIMED CAPITAL GP II LLC's Net Worth
XLRN Historical Data
Astellas Pharma Inc
Acceleron Corp Becomes a Digital Correspondent Bank
Pharma Contract Sales Market Report 2022-2032
19 Charts to Calm Your Recession Fears
XLRN May 2022 140.000 put
Merck Closes Biggest Biotech Deal of the Year
Some Acceleron Investors Want a Better Deal From Merck
Acceleron: Q3 Earnings Snapshot
Acceleron Reports Third Quarter 2021 Financial Results
Merck (MRK) to Report Q3 Earnings: What's in the Cards?
3 Reasons to Buy Merck Stock Right Now
Get Acceleron Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter.

Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

XLRN Media Mentions By Week

XLRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XLRN
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

XLRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XLRN Articles
This Week

0

0

XLRN Articles
Average Week

Get Acceleron Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:XLRN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners